KHN Morning Briefing

Summaries of health policy coverage from major news organizations

FDA Approves Plan B Pill, Ends Long Fight

The FDA on Thursday approved over-the-counter sales without age restriction for the Plan B emergency contraceptive pill, ending a decade-long fight over the pill.

Los Angeles Times: With FDA Approval, Fight Ends Over Morning-After Pill
The Food and Drug Administration on Thursday approved the emergency contraceptive Plan B One-Step for use without a prescription or age restrictions, effectively ending more than a decade of legal and regulatory wrangling over the controversial morning-after pill. In a statement, the FDA said its action complied with an order by U.S. District Judge Edward Korman of New York, who had openly criticized the George W. Bush and Obama administrations for imposing restrictions on the sale of the pill for political reasons (Morin, 6/20).

Politico: FDA Approves Morning-After Pill for Over-The-Counter Sale
The Obama administration had been fighting in court to preserve restricted access for younger teens, but recently dropped the case after legal setbacks. The FDA then told the court it would quickly approve an application for over-the-counter sale by Teva, the manufacturer of Plan B One-Step (Norman, 6/20).

This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.